Skip to main content

Table 2 Cardiometabolic complications developed by subjects during the following (divided by BMI and metabolic health). Models were adjusted by sex, BMI, age, smoking, physical activity and family history of T2D and hypertension

From: Natural course of metabolically healthy phenotype and risk of developing Cardiometabolic diseases: a three years follow-up study

Cardiometabolic outcome Phenotype Beta Wald HR 95CI% p
Type 2 Diabetes MHL
MUHL 0.539 2.086 1.715 0.825–3.564 0.149
MHO −0.188 0.459 0.829 0.481–1.427 0.498
MUHO 0.795 9.044 2.214 1.319–3.716 0.003
Hypertension MHL
MUHL 0.961 40.583 2.615 1.946–3.515 < 0.001
MHO 0.192 2.277 1.211 0.944–1.554 0.131
MUHO 0.857 47.127 2.355 1.844–3.007 < 0.001